Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines.
Jean-Yves Winum, Fabrizio Carta, Carol Ward, Peter Mullen, David Harrison, Simon P Langdon, Alessandro Cecchi, Andrea Scozzafava, Ian Kunkler, Claudiu T Supuran, Jean-Yves Winum, Fabrizio Carta, Carol Ward, Peter Mullen, David Harrison, Simon P. Langdon, Alessandro Cecchi, Andrea Scozzafava, Ian Kunkler, Claudiu T. Supuran, Jean-Yves Winum, Fabrizio Carta, Carol Ward, Peter Mullen, David Harrison, Simon P Langdon, Alessandro Cecchi, Andrea Scozzafava, Ian Kunkler, Claudiu T Supuran
Index: Bioorg. Med. Chem. Lett. 22(14) , 4681-5, (2012)
Full Text: HTML
Abstract
A series of 50 sulfamates were obtained by reacting 4-aminophenol with isocyanates followed by sulfamoylation. Most of the new compounds were nanomolar inhibitors of the tumor-associated carbonic anhydrase (CA, EC 4.2.1.1) isoforms IX and XII, whereas they inhibited less cytosolic offtarget isoforms CA I and II. Some of these sulfamates showed significant antiproliferative activity in several breast cancer cell lines, such as SKBR3, MCF10A, ZR75/1, MDA-MB-361 and MCF7, constituting interesting anticancer leads.Copyright © 2012 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
2012-02-15
[Bioorg. Med. Chem. 20 , 1403-10, (2012)]
2015-01-01
[PLoS ONE 10 , e0141897, (2015)]
2014-11-01
[Clin. Rheumatol. 33(11) , 1557-64, (2014)]
2012-12-01
[Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 99 , 223-33, (2012)]
2012-07-04
[J. Am. Chem. Soc. 134(26) , 10807-10, (2012)]